4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-331299
VP, Finance and Controller sold 389 shares at $8.68 ($3,377)
- VP, Finance and Controller acquired 1,086 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gupta Ashoo · VP, Finance and Controller
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-20 | Exercise or conversion : show line 1 in the form | +866 | 46,528 | D | ||
| 2025-12-20 | Sale : show line 2 in the form | −310 | $8.68 | $2,691 | 46,218 | D |
| 2025-12-20 | Exercise or conversion : show line 3 in the form | +220 | 46,438 | D | ||
| 2025-12-20 | Sale : show line 4 in the form | −79 | $8.68 | $686 | 46,359 | D |
| Open-market sales · 389 sh · avg $8.68 · $3,377 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-20 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −866 | 12,984 | D |
| 2025-12-20 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −220 | 3,308 | D |
Loading xslF345X05/ownership.xml…